FNP-223 is currently being investigated in a phase 2 trial evaluating the treatment in adults with possible or probable PSP-Richardson syndrome.

Skyhawk Therapeutics, Inc., a clinical-stage biotechnology company developing novel small molecule therapies designed to ...

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today introduced Visionaire™ to support researchers in addressing data reproducibility, ...

Dental technicians meticulously craft crowns and dentures to ensure both function and appearance.

Recent developments in restorative materials and adhesive strategies, alongside enhanced insights into caries pathology, have set the stage for selective caries excavation, vital pulp therapy, and ...